ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,393.80
0.85%
S&P ASX All Technology
3,840.60
-1.02%
Brent Oil
74.295
0.49%
US Dollar vs AUD
1.53806
0.12%
Bitcoin
99,332.96
0.83%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Enlivex Therapeutics Ltd (ENLV) Share Price

Enlivex Therapeutics Ltd

Enlivex Therapeutics Ltd (ENLV)

NASDAQ
0.841
-0.135
(-13.83%)
Closed 22 November 8:00AM
Delayed by 15 minutes
0.88
0.039
(4.64%)
After Hours: 11:18AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
0.88
Bid
0.84
Offer
0.87
Volume
411,648
0.8101 Day's Range 1.02
0.866577 52 Week Range 4.59
Market Cap
18.374M
Previous Close
0.976
Open
1.01
Last Trade
75
@
0.87
Last Trade Time
Financial Volume
US$ 369,800
VWAP
0.898341
Average Volume (3m)
137,344
Shares Outstanding
20,880,000
Dividend Yield
-
PE Ratio
-0.62
Earnings Per Share (EPS)
-1.39
Revenue
-
Net Profit
-29.07M

About Enlivex Therapeutics Ltd

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threate... Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.enlivex.com
Headquarters
Ness Ziona, Center, Isr
Founded
-
Enlivex Therapeutics Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ENLV. The last closing price for Enlivex Therapeutics was US$0.98. Over the last year, Enlivex Therapeutics shares have traded in a share price range of US$ 0.866577 to US$ 4.59.

Enlivex Therapeutics currently has 20,880,000 shares in issue. The market capitalisation of Enlivex Therapeutics is US$20.38 million. Enlivex Therapeutics has a price to earnings ratio (PE ratio) of -0.62.

Ask ADVFN Intelligence (AI)

ENLV Latest News

More News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

21 November 2024
Edgar (US Regulatory)

Enlivex Adopts Bitcoin Treasury Reserve Strategy

Nes-Ziona, Israel, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced...

21 November 2024
GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

15 November 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

15 November 2024
Edgar (US Regulatory)

Enlivex Announces the Dosing of the First Patient in a Phase I Clinical Trial Evaluating Allocetra in Patients with Psoriatic Arthritis

Nes-Ziona, Israel, Nov. 14, 2024 (GLOBE NEWSWIRE) --  Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced...

15 November 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

13 November 2024
Edgar (US Regulatory)

Enlivex Announces the Enrollment and Dosing of the First 10 Patient in the Randomized Phase II Stage of its Allocetra Trial in Patients with Moderate to Severe Knee Osteoarthritis

Nes-Ziona, Israel, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced...

13 November 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

01 November 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

30 October 2024
Edgar (US Regulatory)

Enlivex Receives Notice of Allowance for Japanese Patent Application Covering the Use of Allocetra™ in Patients with Osteoarthritis

Nes-Ziona, Israel, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced...

30 October 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.29-24.78632478631.171.170.8665771832821.02595835CS
4-0.72-451.61.650.8665771650311.25549226CS
12-0.37-29.61.251.750.8665771373441.42461825CS
26-0.56-38.88888888891.441.750.866577931091.40467338CS
52-0.79-47.30538922161.674.590.8665771141912.0437631CS
156-7.01-88.84664131817.898.640.866577675753.20840223CS
260-7.44-89.42307692318.3229.40.8665771685889.2589736CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WORXSCWorx Corporation
US$ 2.12
(116.33%)
144.39M
CRNCCerence Inc
US$ 5.83
(106.74%)
77.56M
PROCProcaps Group SA
US$ 1.10
(92.48%)
2.58M
IBGInnovation Beverage Group Limited
US$ 1.19
(50.40%)
12.97M
ARQQArqit Quantum Inc
US$ 10.7599
(46.59%)
900.38k
SKKSKK Holdings Limited
US$ 1.01
(-77.85%)
40.47M
TMTCTMT Acquisition Corporation
US$ 2.20
(-65.84%)
530.14k
WCTWellchange Holdings Company Limited
US$ 1.2596
(-62.06%)
2.34M
TMTCUTMT Acquisition Corporation
US$ 2.89
(-56.74%)
14.07k
GLXGGalaxy Payroll Group Ltd
US$ 1.77
(-54.73%)
2.45M
CDTConduit Pharmaceuticals Inc
US$ 0.1048
(13.54%)
573.38M
NVDANVIDIA Corporation
US$ 146.67
(0.53%)
387.95M
ELABElevai Labs Inc
US$ 0.020072
(-6.21%)
255.32M
AKTSAkoustis Technologies Inc
US$ 0.1022
(17.34%)
210.12M
MARAMARA Holdings Inc
US$ 24.19
(6.89%)
163.27M

ENLV Discussion

View Posts
glenn1919 glenn1919 2 months ago
ENLV.........................................https://stockcharts.com/h-sc/ui?s=ENLV&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 8 months ago
ENLV under $4
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
ENLV...NEXT BIO BEAST READY TO break out
👍️0
MOCKBA MOCKBA 6 years ago
I see ok, they should send a PR about it!
👍️0
dinogreeves dinogreeves 6 years ago
I mean that ENLV is now Nasdaq compliant, there are no issues with Nasdaq on their filings,
👍️0
MOCKBA MOCKBA 6 years ago
What you mean by that?
👍️0
dinogreeves dinogreeves 6 years ago
ENLV Nasdaq compliant now, should get a press release soon.
👍️0
dinogreeves dinogreeves 6 years ago
checkout website you'll be impressed

https://www.enlivex.com
👍️0
MOCKBA MOCKBA 6 years ago
Dino, grabbed a small position, looks very intriguing to say the least
👍️0
dinogreeves dinogreeves 6 years ago
They have over 35 million in cash man, no dilution for at least 2 years. Buy ENLV with everything you got.
👍️0
dinogreeves dinogreeves 6 years ago
This is ENLV now, buy all you can, they reverse merged with ORPN
👍️0
dinogreeves dinogreeves 6 years ago
This is one the best bios out there, soon to surpass what BPTH did
👍️0
whytestocks whytestocks 6 years ago
News: $ORPN Bioblast Announces Effectiveness of Eight to One Reverse Split

Tel Aviv, Israel, March 06, 2019 (GLOBE NEWSWIRE) -- Bioblast Pharma Ltd. (NasdaqCM: ORPN), a clinical-stage, orphan disease-focused biotechnology company, announced the effectiveness of an eight to one reverse split of its share capital. As previously reported, the reverse split was approv...

Find out more https://marketwirenews.com/news-releases/bioblast-announces-effectiveness-of-eight-to-one-reverse-split-7810132.html
👍️0
ClayTrader ClayTrader 6 years ago
* * $ORPN Video Chart 02-19-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 6 years ago
* * $ORPN Video Chart 11-20-18 * *

Link to Video - click here to watch the technical chart video

👍️0
r1aviator r1aviator 6 years ago
$ORPN

Bioblast Pharma Ltd. Announces Entry Into Merger Agreement to Acquire Enlivex Therapeutics Ltd. to Advance Clinical Stage Immunotherapeutic Drug Pipeline for the Treatment of Life-Threatening Diseases Sepsis, GvHD and Solid Tumors

https://twitter.com/birdseyepix/status/1064655592529117184?s=21
👍️0
r1aviator r1aviator 6 years ago
Running :)

$ORPN
👍️0
r1aviator r1aviator 6 years ago
Took a starter

$ORPN
👍️0
ClayTrader ClayTrader 7 years ago
* * $AXXA Video Chart 05-18-18 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 7 years ago
* * $SDRL Video Chart 05-18-18 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 7 years ago
* * $ORPN Video Chart 05-18-18 * *

Link to Video - click here to watch the technical chart video

👍️0
europtiger europtiger 7 years ago
Crazy downer but buying more 3,10 as i belive Shorts will bien there Fingers
👍️0
europtiger europtiger 7 years ago
Looking good

Nice bids coming in

👍️0
crudeoil24 crudeoil24 7 years ago
Very nice call! Blast off > Blast Pharma! orpn
👍️0
europtiger europtiger 7 years ago
Here we Go
👍️0
europtiger europtiger 7 years ago
Yep float has been traded allready

Hope for breakout just bought more

But stop is in
👍️0
crudeoil24 crudeoil24 7 years ago
Traders running this low floater > Brooklyn!
👍️0
europtiger europtiger 7 years ago
Got 2,90‘s
👍️0
Golden Cross Golden Cross 7 years ago
ORPN cheat sheet:

https://www.barchart.com/stocks/quotes/ORPN/cheat-sheet
👍️0
Golden Cross Golden Cross 7 years ago
Short squeeze info:


http://shortsqueeze.com/?symbol=orpn&submit=Short+Quote%E2%84%A2
👍️0
Golden Cross Golden Cross 7 years ago
MACD looking bullish
👍️0
Golden Cross Golden Cross 7 years ago
Chart shaping up:

👍️0
DewDiligence DewDiligence 7 years ago
Caveat emptor! This looks like a financing deal is coming soon.
👍️0
europtiger europtiger 7 years ago
Running hard

Super Low Float
👍️0
Me stocks Me stocks 7 years ago
This one is investment. It will go to 15$ at least in 2018.
👍️0
Awl416 Awl416 7 years ago
That was fast
👍️0
DewDiligence DewDiligence 7 years ago
ORPN 9/30/17 cash=$4.1M (down from $5.2M at 6/30/17):

https://finance.yahoo.com/news/bioblast-pharma-reports-third-quarter-113000168.html
👍️0
DewDiligence DewDiligence 7 years ago
1:5 reverse split is effective today (eom).
👍️0
DewDiligence DewDiligence 7 years ago
ORPN implements 1:5 reverse split effective on date to be announced:

https://www.sec.gov/Archives/edgar/data/1596812/000114420417048497/v475345_6k.htm
👍️0
jcbaby jcbaby 7 years ago
you are correct this play could rise very very fast
👍️0
theprofit444 theprofit444 7 years ago
its a revised outlook lmaooooo
👍️0
jcbaby jcbaby 7 years ago
didn't you say 10 awhile back lol lets hope for anything but its current price
👍️0
theprofit444 theprofit444 7 years ago
itll be 4 dollars a share by yr end
👍️0
DewDiligence DewDiligence 7 years ago
ORPN 2Q17 PR:

https://www.sec.gov/Archives/edgar/data/1596812/000114420417040598/v472433_ex99-1.htm

6/30/17 cash was $5.2M.
👍️0
jcbaby jcbaby 7 years ago
this could rocket over a dollar in a swift blow got to be ready
👍️0
DewDiligence DewDiligence 7 years ago
Two months has elapsed since the post I'm replying to. They'd better come up with a plan soon.
👍️0
stocktrademan stocktrademan 7 years ago
ORPN buy 0.656

inverted head and shoulders bottom
bullish divergence breakout and initial pullback level
high volume on advances, lower volume on retracements indicates strong demand for the stock
pennant breakout soon
breaking out over the ichimoku cloud
moving average golden cross pattern









normal chart




log chart



👍️0
jcbaby jcbaby 7 years ago
should be an interesting day for this stock will see?
👍️0
ClayTrader ClayTrader 7 years ago
* * $ORPN Video Chart 06-30-17 * *

Link to Video - click here to watch the technical chart video

👍️0
Klinsmann Klinsmann 7 years ago
Indeed! On a day it made nearly 100% off of its lows...
👍️0

Your Recent History

NASDAQ
ENLV
Enlivex Therapeutics
BIT
P1IB76
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved